GSK PLC (GSK)
33.70
+0.35
(+1.05%)
USD |
NYSE |
Nov 21, 16:00
33.69
-0.01
(-0.03%)
Pre-Market: 20:00
GSK Total Assets (Quarterly): 77.68B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 77.68B |
| June 30, 2024 | 73.44B |
| March 31, 2024 | 73.87B |
| December 31, 2023 | 75.17B |
| September 30, 2023 | 74.26B |
| June 30, 2023 | 75.00B |
| March 31, 2023 | 72.57B |
| December 31, 2022 | 72.79B |
| September 30, 2022 | 67.35B |
| June 30, 2022 | 108.00B |
| March 31, 2022 | 117.82B |
| December 31, 2021 | 106.76B |
| September 30, 2021 | 105.66B |
| June 30, 2021 | 106.58B |
| March 31, 2021 | 107.32B |
| December 31, 2020 | 109.61B |
| September 30, 2020 | 104.10B |
| June 30, 2020 | 104.18B |
| March 31, 2020 | 104.38B |
| December 31, 2019 | 104.49B |
| September 30, 2019 | 102.32B |
| June 30, 2019 | 80.64B |
| March 31, 2019 | 81.34B |
| December 31, 2018 | 73.68B |
| September 30, 2018 | 76.36B |
| Date | Value |
|---|---|
| June 30, 2018 | 75.35B |
| March 31, 2018 | 78.71B |
| December 31, 2017 | 76.19B |
| September 30, 2017 | 78.94B |
| June 30, 2017 | 75.76B |
| March 31, 2017 | 73.91B |
| December 31, 2016 | 72.58B |
| September 30, 2016 | 76.21B |
| June 30, 2016 | 77.58B |
| March 31, 2016 | 78.29B |
| December 31, 2015 | 79.18B |
| September 30, 2015 | 80.50B |
| June 30, 2015 | 85.10B |
| March 31, 2015 | 85.88B |
| December 31, 2014 | 63.27B |
| September 30, 2014 | 65.45B |
| June 30, 2014 | 66.17B |
| March 31, 2014 | 66.09B |
| December 31, 2013 | 69.40B |
| September 30, 2013 | 66.46B |
| June 30, 2013 | 64.16B |
| March 31, 2013 | 65.18B |
| December 31, 2012 | 67.03B |
| September 30, 2012 | 65.65B |
| June 30, 2012 | 65.88B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
67.35B
Minimum
Sep 2022
117.82B
Maximum
Mar 2022
92.05B
Average
104.14B
Median
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 104.92B |
| Pfizer Inc | 219.48B |
| Sanofi SA | -- |
| Moderna Inc | 15.80B |
| Autolus Therapeutics PLC | 827.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 59.68B |
| Shareholders Equity (Quarterly) | 18.75B |
| Debt to Equity Ratio | 1.146 |
| Current Ratio | 0.8061 |
| Net Debt Paydown Yield | 1.34% |